Downregulation of the renal and hepatic hydrogen sulfide (H 2S)-producing enzymes and capacity in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 498-504

  Aminzadeh, Mohammad A ^a   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; CKD progression; hypertension; inflammation; oxidative stress

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; 3 MERCAPTOPYRUVIC ACID; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; SULFURTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME REGULATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; HYDROGEN SULFIDE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIVER; MALE; MALONDIALDEHYDE; NEPHRECTOMY; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; THIOBARBITURATES;

EID: 84856933273     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr560     Document Type: Article

References (58)

1. Fujihara CK, Antunes GR, Mattar AL et al. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol 2007; 292: F92-F99
2. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12: 593-598
3. Himmelfarb J, Stenvinkel P, Ikizler TA et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538
4. Manning RD Jr, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 2005; 25: 311-317
5. Quiroz Y, Ferrebuz A, Romero F et al. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol 2008; 294: F336-F344
6. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296
7. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
8. Yoon JW, Pahl MV, Vaziri ND. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int 2007; 71: 167-172
9. Cho KH, Kim HJ, Rodriguez-Iturbe B et al. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 2009; 297: F106-F113
10. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 93-99
11. Vaziri ND, Moradi H, PahlMV et al. In vitro stimulation of HDL antiinflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int 2009; 76: 437-444
12. Vaziri ND, Ni Z, Oveisi F et al. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39: 135-141
13. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53: 1748-1754
14. Kim HJ, Moradi H, Yuan J et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 2009; 296: F1297-F1306
15. Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem 2010; 113: 14-26
16. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA 2007; 104: 17907-17908
17. Martin GR, McKnight GW, Dicay MS et al. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis 2010; 42: 103-109
18. Zhao W, Zhang J, Lu Y et al. The vasorelaxant effect of H (2) S as a novel endogenous gaseous K (ATP) channel opener. EMBO J 2001; 20: 6008-6016
19. Jackson-Weaver O, Paredes DA, Gonzalez Bosc LV et al. Intermittent hypoxia in rats increases myogenic tone through loss of hydrogen sulfide activation of large-conductance Ca(21)-activated potassium channels. Circ Res 2011; 108: 1439-1447
20. Xia M, Chen L, Muh RW et al. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 2009; 329: 1056-1062
21. Bełtowski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther 2010; 334: 358-363
22. Heyman SN, Brezis M, Greenfeld Z et al. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989; 14: 377-385
23. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 43-50
24. Ali MY, Ping CY, Mok YY et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 2006; 149: 625-634
25. Laggner H, Muellner MK, Schreier S et al. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res 2007; 41: 741-747
26. Whiteman M, Armstrong JS, Chu SH et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 2004; 90: 765-768
27. Whiteman M, Cheung NS, Zhu YZ et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 2005; 326: 794-798
28. Whiteman M, Li L, Kostetski I et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 2006; 343: 303-310
29. Muzaffar S, Shukla N, Bond M et al. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res 2008; 45: 521-528
30. Tyagi N, Moshal KS, Sen U et al. H2S protects against methionineinduced oxidative stress in brain endothelial cells. Antioxid Redox Signal 2009; 11: 25-33
31. Muellner MK, Schreier SM, Laggner H et al. Hydrogen sulfide destroys lipid hydro peroxides in oxidized LDL. Biochem J 2009; 420: 277-281
32. Schreier SM, Muellner MK, Steinkellner H et al. Hydrogen sulfide scavenges the cytotoxic lipid oxidation product 4-HNE. Neurotox Res 2010; 17: 249-256
33. Jha S, Calvert JW, Duranski MR et al. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 2008; 295: H801-H806
34. Kimura Y, Dargusch R, Schubert D et al. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 2006; 8: 661-670
35. Kimura Y, Goto Y, Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 2010; 12: 1-13
36. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004; 18: 1165-1167
37. Liu YY, Bian JS. Hydrogen sulfide protects amyloid-b induced cell toxicity in microglia. J Alzheimers Dis 2010; 22: 1189-1200
38. Yin WL, He JQ, Hu B et al. Hydrogen sulfide inhibits MPP (1)-induced apoptosis in PC12 cells. Life Sci 2009; 85: 269-275
39. Calvert JW, Elston M, Nicholson CK et al. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 2010; 122: 11-19
40. Calvert JW, Jha S, Gundewar S et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009; 105: 365-374
41. Perna AF, Lanza D, Sepe I et al. Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it? Blood Purif 2011; 31: 102-106
42. Sen U, Munjal C, Qipshidze N et al. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 2010; 31: 442-455
43. Tripatara P, Patel NS, Collino Met al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048
44. Perna AF, Luciano MG, Ingrosso D et al. Hydrogen sulphidegenerating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 2009; 24: 3756-3763
45. Perna AF, Luciano MG, Ingrosso D et al. Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients. J Ren Nutr 2010; 20: S11-S14
46. Vaziri ND, Bai Y, Ni Z et al. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007; 323: 85-93
47. Li L, Bhatia M, Zhu YZ et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198
48. Naito C, Yamanaka T. Lipid peroxides in atherosclerotic diseases. Nippon Ronen Igakkai Zasshi 1978; 15: 187-191
49. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278
50. Johnson D, Lardy H. Isolation of liver or kidney mitochondria. Methods Enzymol 1967; 10: 94-96
51. Jung K, Pergande M. Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 1985; 183: 167-169
52. Itzhaki RF, Gill DM. A Micro-Biuret method for estimating proteins. Anal Biochem 1964; 9: 401-410
53. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 2010; 298: F662-F671
54. Li W, Khor TO, Xu C et al. Activation of Nrf2-antioxidant signaling attenuates NF-KB inflammatory response and elicits apoptosis. Biochem Pharmacol 2008; 76: 1485-1489
55. Kabil O, Vitvitsky V, Xie P et al. The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues. Antioxid Redox Signal 2011; 15: 363-372
56. Hasuike Y, Nakanishi T, Moriguchi R et al. Accumulation of cyanide and thiocyanate in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1474-1479
57. Billaut-Laden I, Rat E, Allorge D et al. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme. Toxicol Lett 2006; 165: 101-111
58. Mudd SH. Hypermethioninemias of genetic and non-genetic origin: a review. Am J Med Genet C Semin Med Genet 2011; 157: 3-32